Thu, 29 September 2016
Pepsi’s 3rd quarter was strong thanks to Frito-Lay. TD Ameritrade rises on reports it may buy out rival Scottrade. And Medtronic gets FDA approval for an artificial pancreas. Plus we dip into the Fool Mailbag with Bill Mann and Bryan Hinmon from Motley Fool Funds. Thanks to Pearl Auto for supporting this episode. Go to http://PearlAuto.com/Fool to get free 2-day shipping!